Arlington Financial Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $223K | Sell |
500
-40
| -7% | -$17.8K | 0.04% | 80 |
|
|
2025
Q1 | $262K | Buy |
540
+5
| +0.9% | +$2.42K | 0.05% | 97 |
|
|
2024
Q4 | $215K | Buy |
535
+35
| +7% | +$14.1K | 0.04% | 90 |
|
|
2024
Q3 | $233K | Sell |
500
-35
| -7% | -$16.3K | 0.05% | 69 |
|
|
2024
Q2 | $251K | Buy |
535
+35
| +7% | +$16.4K | 0.06% | 63 |
|
|
2024
Q1 | $209K | Hold |
500
| – | – | 0.05% | 70 |
|
|
2023
Q4 | $203K | Buy |
+500
| New | +$203K | 0.06% | 77 |
|
|
2020
Q4 | – | Sell |
-900
| Closed | -$245K | – | 62 |
|
|
2020
Q3 | $245K | Hold |
900
| – | – | 0.13% | 50 |
|
|
2020
Q2 | $261K | Hold |
900
| – | – | 0.15% | 53 |
|
|
2020
Q1 | $214K | Buy |
+900
| New | +$214K | 0.15% | 48 |
|